Cargando…
Dexamethasone/hydroxychloroquine: Reactivation of COVID-19 infection and off label use: 4 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843880/ http://dx.doi.org/10.1007/s40278-021-90294-z |
Ejemplares similares
-
Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
Publicado: (2020) -
Cladribine/hydroxychloroquine: COVID-19-pneumonia, lymphopenia and off label use: case report
Publicado: (2020) -
Dexamethasone: Reactivation of Strongyloides stercoralis following off-label use: 2 case reports
Publicado: (2021) -
Dexamethasone/mycophenolate mofetil/prednisolone: Cytomegalovirus reactivation and off label use: case report
Publicado: (2022) -
Hydroxychloroquine: Rash following off label use: case report
Publicado: (2020)